Company profilePharmaceutical#137 of 1,318 in Pakistan✓ No DRAP alerts

Wilson's Pharmaceuticals

Pharmaceutical company · 120 brands · 51 molecules

120 registered products 54 pharmaceutical brands 51 distinct molecules 0 DRAP alerts

Company overview

120
registered products
54
pharmaceutical brands
51
distinct molecules
0
therapeutic classes
0
DRAP alerts

Wilson's Pharmaceuticals is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 120 product registrations across 51 distinct molecules. It is the 137th largest registrant in Pakistan by product count. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Top molecules by brand count

Amlodipine6 brands
Bisoprolol5 brands
Budesonide4 brands
Amoxicillin4 brands
Metformin4 brands
Levofloxacin4 brands
Ibuprofen4 brands

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official120 products · Rs 21.24 – Rs 19,004.31
Median across source: Rs 343.94

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

Get the full profile for Wilson's

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.